摘要 |
Compounds having the formula (I), and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are surprisingly advantageous as p38 kinase inhibitors, wherein R<SUB>3 </SUB>is hydrogen, methyl, perfluoromethyl, methoxy, halogen, cyano, NH<SUB>2</SUB>, or NH(CH<SUB>3</SUB>), preferably methyl; X is N or CH; and R<SUB>1 </SUB>through R<SUB>6 </SUB>are as described in the specification.
|